Scott Kelley, MD
Pacira Pharmaceuticals, Inc
4
0
2
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hillary Overholser
Zimmer Biomet
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Karen Sepucha, PhD
Massachusetts General Hospital
Shared therapeutic areas:
Erin Osborn
Zimmer Biomet
Shared therapeutic areas:
Volkan Şah
Yüzüncü Yıl Üniversitesi Tıp Fakültesi
Shared therapeutic areas:
Abdul Ghafoor Sajjad, Phd*
Riphah International University
Shared therapeutic areas:
Carol A Mancuso, MD
Hospital for Special Surgery, New York
Shared therapeutic areas:
Paola Vivoda
Zimmer Biomet
Shared therapeutic areas:
Brian M Ilfeld, M.D., M.S.
University of California, San Diego
Shared therapeutic areas:
Aisha Razzaq, MSPT-OMPT
Riphah International University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis
Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip
Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA
All 4 trials loaded